Senate Democrats press HHS over FDA firings
In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.
The Ozempic shortage is over, a big threat to off-brand weight loss drug sellers
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
US Health Agencies Postpone Rare Disease Day
"After much consideration, we are postponing FDA-NIH Rare Disease Day 2025 and will reschedule it to occur in the coming months," a notice on the FDA's website showed. Rare Disease Day is observed ...
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
DOGE Cuts Hit Federal Workers Who Aren’t Funded by Taxpayers
Fees paid to agencies like the Food and Drug Administration and the FDIC fund part of their workforces, so cutting those jobs ...
Why Novo Nordisk Stock Popped on Friday
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
F.D.A. Firings Decimated Teams Reviewing A.I. and Food Safety
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
US FDA approves Mirum Pharma's genetic disorder drug
The U.S. Food and Drug Administration said on Friday it has approved Mirum Pharmaceuticals' drug to treat a type of rare disorder, which affects the body's ability to metabolize fats known as ...